GlassScriptPhysician profile
Merna Mg Abdou
NPI 1134758279
$4,822.93
in general payments reported to CMS, 2019-2025
23 companies · $3,021 in 2025
The $3,021 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $659 · 2024: $1,144 · 2025: $3,021.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,286 · Travel and Lodging: $1,022 · Education: $515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,286.00 |
| Travel and Lodging | $1,021.73 |
| Education | $515.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $1,450.91 | 2024-2025 | Barostim Neo System |
| Abbott Laboratories | $819.08 | 2023-2025 | Ensite, Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $588.00 | 2024-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $338.43 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $246.83 | 2025 | Cobenfy, Camzyos |
| Medtronic, INC. | $228.39 | 2023 | Onyx Frontier, Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Boston Scientific Corporation | $195.45 | 2024 | Avvigo Guidance System, Sentinel |
| Shockwave Medical, INC | $142.03 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Bridgebio Pharma, INC. | $128.47 | 2025 | Attruby |
| Merck Sharp & Dohme LLC | $120.25 | 2025 | Winrevair |
| United Therapeutics Corporation | $106.14 | 2024 | Tyvaso |
| Bayer Healthcare Pharmaceuticals INC. | $94.88 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $69.43 | 2024 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $60.02 | 2024-2025 | Farxiga, Wainua |
| Lantheus Medical Imaging, INC. | $41.31 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $38.36 | 2025 | Evkeeza |
| Abiomed | $33.40 | 2025 | |
| Novo Nordisk INC | $24.30 | 2024 | Rybelsus, Ozempic |
| Kiniksa Pharmaceuticals, LTD. | $23.65 | 2023 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $21.43 | 2025 | Amvuttra |
| Baxter Healthcare | $17.90 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Philips North America LLC | $17.28 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $16.99 | 2025 | Opsumit, Uptravi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Merna Abdou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.